NCT02503189View on ClinicalTrials.gov

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2017

Conditions
Dry Eye With Sjögren's Syndrome
Interventions
DRUG

KCT-0809 ophthalmic solution

DRUG

Placebo

Trial Locations (1)

Unknown

Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY